The difference between making a discovery and harnessing its power

Our target identification screens and drug discovery programs represent the potential of identifying and developing precision therapeutics. We are tackling multiple diseases through new in-depth clinically focused screens and advance novel targets identified through single-cell RNA sequencing analysis to rapid drug discovery.